|
Volumn 34, Issue 5, 2002, Pages 1906-1908
|
Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CILASTATIN;
FLUCONAZOLE;
IMIPENEM;
METHYLPREDNISOLONE;
SULFAMETHOXAZOLE;
TRIMETHOPRIM;
IMMUNOSUPPRESSIVE AGENT;
LYMPHOCYTE ANTIBODY;
TACROLIMUS;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
FEMALE;
HEMODIALYSIS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
KIDNEY TRANSPLANTATION;
MALE;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
SURGICAL TECHNIQUE;
SURVIVAL RATE;
ADULT;
ARTICLE;
CHRONIC KIDNEY FAILURE;
DIABETIC NEPHROPATHY;
DRUG COMBINATION;
GRAFT SURVIVAL;
IMMUNOLOGY;
INSULIN DEPENDENT DIABETES MELLITUS;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
PHYSIOLOGY;
TIME;
ADULT;
ANTILYMPHOCYTE SERUM;
DIABETES MELLITUS, INSULIN-DEPENDENT;
DIABETIC NEPHROPATHIES;
DRUG THERAPY, COMBINATION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MIDDLE AGE;
PANCREAS TRANSPLANTATION;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
DIABETES MELLITUS, TYPE 1;
HUMANS;
MIDDLE AGED;
|
EID: 0035993807
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03118-4 Document Type: Conference Paper |
Times cited : (2)
|
References (11)
|